The acquisition would build Roche’s palette of health diagnostics products and potentially allow the company to better target its medicines toward individual patients. Illumina said Jan. 10 that by the end of the year it would market a machine capable...

Ltd. with making $63,000 in illegal profits on inside information about the company's 2008 agreement to acquire Millennium Pharmaceuticals Inc. The former U.S.-based employee, Brent Bankosky, has partially settled the civil lawsuit by the U.S....

Both companies have said they're unlikely to develop in-house divisions focused on diagnostics--as Roche ($RHHBY) and Abbott Laboratories ($ABT) have--but to take a more piecemeal approach. GSK CFO Simon Dingemans told Bloomberg the company doesn't...

Ltd. has reached a partial settlement with the U.S. Securities and Exchange Commission over allegations that he made $63,000 on insider trading. After the SEC today made public a 16-page complaint against Brent Bankosky, his lawyer told Reuters that a...

Bankosky failed to profit from his trades in those companies’ securities, the SEC said. Elissa Johnsen, a spokeswoman for Osaka, Japan-based Takeda Pharmaceutical Co.’s North American unit, didn’t immediately return a voice-mail message seeking...

(4502) executive was accused of using inside information to make more than $63,000 trading in call options, according a lawsuit filed by the U.S. Securities and Exchange Commission. Brent Bankosky, a former director in Takeda’s business development...